Host modulators of H1N1 cytopathogenicity

Area of Science:

• Virology
• Cell Biology
• Pharmacology

Background:

• Influenza A virus causes significant annual mortality and morbidity.
• Current vaccines and antiviral drugs face challenges due to rapid viral evolution and drug resistance.
• Targeting host factors presents a promising alternative intervention strategy.

Purpose of the Study:

• To identify host cell factors crucial for H1N1 influenza A virus infection in human bronchial epithelial cells.
• To uncover druggable host gene products that support viral replication or viral evasion of host cell death.
• To explore novel therapeutic targets beyond viral proteins.

Main Methods:

• Utilized arrayed whole-genome siRNA screening to identify host factors.
• Integrated public datasets to find druggable gene products.
• Employed pharmacological inhibition of identified targets (RGGT and CHEK1).

Main Results:

• Identified cell-autonomous molecular components supporting H1N1 influenza A virus infection.
• RGGT and CHEK1 were found to be druggable targets.
• Inhibition of RGGT and CHEK1 significantly protected human epithelial cells against A/WS/33 virus infection.
• RGGT inhibition provided partial protection against H5N1 and the 2009 H1N1 pandemic strain.

Conclusions:

• Host-directed therapies targeting RGGT and CHEK1 show potential for influenza treatment.
• This study decodes vulnerabilities in host cell networks exploited by influenza viruses.
• Findings contribute to developing new strategies to combat influenza by targeting host factors.